$1.66 Billion is the total value of Bain Capital Public Equity Management, LLC's 55 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 147.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HON | New | HONEYWELL INTL INC | $151,186,000 | – | 1,134,265 | +100.0% | 9.10% | – |
AABA | New | ALTABA INC | $142,023,000 | – | 2,606,887 | +100.0% | 8.55% | – |
NOC | Buy | NORTHROP GRUMMAN CORP | $107,881,000 | +32.5% | 420,243 | +22.8% | 6.49% | +12.6% |
PNR | Buy | PENTAIR PLC | $87,918,000 | +77.4% | 1,321,273 | +67.3% | 5.29% | +50.7% |
JCI | New | JOHNSON CTLS INTL PLC | $76,382,000 | – | 1,761,567 | +100.0% | 4.60% | – |
GDDY | Buy | GODADDY INCcl a | $71,216,000 | +58.9% | 1,678,837 | +42.0% | 4.29% | +35.0% |
BLL | Buy | BALL CORP | $69,528,000 | +48.2% | 1,647,202 | +160.7% | 4.18% | +25.9% |
VRTX | Buy | VERTEX PHARMACEUTICALS INC | $58,056,000 | +90.2% | 450,498 | +61.4% | 3.49% | +61.7% |
JACK | New | JACK IN THE BOX INC | $54,752,000 | – | 555,854 | +100.0% | 3.30% | – |
FB | Buy | FACEBOOK INCcl a | $54,632,000 | +14.4% | 361,846 | +7.6% | 3.29% | -2.8% |
CTXS | Buy | CITRIX SYS INC | $53,443,000 | -1.3% | 671,559 | +3.4% | 3.22% | -16.1% |
NXPI | Buy | NXP SEMICONDUCTORS N V | $52,208,000 | +161.7% | 477,001 | +147.4% | 3.14% | +122.4% |
NVS | New | NOVARTIS A Gspon adr | $45,845,000 | – | 549,240 | +100.0% | 2.76% | – |
FCEA | New | FOREST CITY RLTY TR INC | $34,541,000 | – | 1,429,080 | +100.0% | 2.08% | – |
MULE | Buy | MULESOFT INCcl a | $32,858,000 | +92.1% | 1,317,471 | +87.4% | 1.98% | +63.3% |
PBYI | Buy | PUMA BIOTECHNOLOGY INC | $29,628,000 | +818.7% | 338,994 | +291.0% | 1.78% | +682.0% |
DLTR | New | DOLLAR TREE INC | $27,978,000 | – | 400,150 | +100.0% | 1.68% | – |
AVXS | Buy | AVEXIS INC | $26,220,000 | +185.0% | 319,138 | +163.8% | 1.58% | +142.4% |
IVZ | New | INVESCO LTD | $24,946,000 | – | 708,900 | +100.0% | 1.50% | – |
COL | New | ROCKWELL COLLINS INC | $23,943,000 | – | 227,851 | +100.0% | 1.44% | – |
AET | New | AETNA INC NEW | $22,453,000 | – | 147,881 | +100.0% | 1.35% | – |
ETFC | New | E TRADE FINANCIAL COR | $22,016,000 | – | 578,900 | +100.0% | 1.32% | – |
DG | New | DOLLAR GEN CORP NEW | $20,589,000 | – | 285,600 | +100.0% | 1.24% | – |
ULTI | New | ULTIMATE SOFTWARE GROUP INC | $14,984,000 | – | 71,330 | +100.0% | 0.90% | – |
CLVS | Buy | CLOVIS ONCOLOGY INC | $13,160,000 | +350.4% | 140,558 | +206.2% | 0.79% | +282.6% |
CLDR | New | CLOUDERA INC | $13,106,000 | – | 886,813 | +100.0% | 0.79% | – |
QQQ | New | POWERSHARES QQQ TRUSTput | $11,401,000 | – | 24,800 | +100.0% | 0.69% | – |
CAR | Buy | AVIS BUDGET GROUP | $10,583,000 | -0.1% | 388,092 | +8.4% | 0.64% | -15.1% |
ALKS | Buy | ALKERMES PLC | $6,341,000 | -88.2% | 109,380 | +19.4% | 0.38% | -89.9% |
GLPG | Buy | GALAPAGOS NVspon adr | $5,443,000 | +15.7% | 71,136 | +30.3% | 0.33% | -1.5% |
CUDA | New | BARRACUDA NETWORKS INC | $5,145,000 | – | 223,100 | +100.0% | 0.31% | – |
DVAX | New | DYNAVAX TECHNOLOGIES CORP | $4,741,000 | – | 491,300 | +100.0% | 0.28% | – |
EPZM | New | EPIZYME INC | $4,331,000 | – | 286,850 | +100.0% | 0.26% | – |
EBSB | New | MERIDIAN BANCORP INC MD | $4,056,000 | – | 240,000 | +100.0% | 0.24% | – |
DKS | New | DICKS SPORTING GOODS | $3,820,000 | – | 95,900 | +100.0% | 0.23% | – |
IMDZ | Buy | IMMUNE DESIGN CORP | $3,797,000 | +607.1% | 389,400 | +393.1% | 0.23% | +502.6% |
VRTX | New | VERTEX PHARMACEUTICALS INCcall | $3,303,000 | – | 2,521 | +100.0% | 0.20% | – |
IWM | Buy | ISHARES TRput | $2,175,000 | -17.8% | 12,500 | +30.2% | 0.13% | -29.9% |
TSRO | New | TESARO INC | $2,028,000 | – | 14,500 | +100.0% | 0.12% | – |
AZN | New | ASTRAZENECA PLCcall | $1,450,000 | – | 10,000 | +100.0% | 0.09% | – |
PTI | New | PROTEOSTASIS THERAPEUTICS IN | $1,233,000 | – | 263,498 | +100.0% | 0.07% | – |
AZN | New | ASTRAZENECA PLCput | $875,000 | – | 10,000 | +100.0% | 0.05% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Brookside Capital Investors, L.P. #1
- Brookside Capital Partners Fund, L.P. #2
- Brookside Capital Investors II, L.P. #3
- Brookside Capital Trading Fund, L.P. #4
- Brookside Capital Investors III, L.P. #5
- Brookside Capital Partners Fund III, L.P. #6
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CITRIX SYS INC | 18 | Q3 2018 | 6.7% |
QUINTILES TRANSNATIO HLDGS I | 18 | Q3 2017 | 3.5% |
AFFIMED N V | 16 | Q1 2019 | 1.0% |
BALL CORP | 13 | Q1 2019 | 7.2% |
RADIUS HEALTH INC | 13 | Q2 2017 | 8.4% |
TRANSDIGM GROUP INC | 11 | Q2 2016 | 10.1% |
ULTA SALON COSMETCS & FRAG I | 11 | Q4 2015 | 5.4% |
VIASAT INC | 11 | Q2 2017 | 7.5% |
AETNA INC NEW | 11 | Q2 2017 | 4.1% |
GODADDY INC | 10 | Q1 2019 | 5.7% |
View Bain Capital Public Equity Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Affimed N.V. | February 14, 2019 | 2,362,813 | 3.8% |
IMMUNE DESIGN CORP. | February 14, 2019 | 892,061 | 1.8% |
REVA Medical, Inc. | February 14, 2019 | 296,502,220 | 7.2% |
MULESOFT, INC | February 14, 2018 | 1,404,025 | 1.9% |
CONCERT PHARMACEUTICALS, INC. | February 28, 2014 | 1,147,833 | 6.7% |
IDENIX PHARMACEUTICALS INC | February 12, 2014 | 13,115,858 | 9.8% |
NORTHSTAR REALTY FINANCE CORP. | February 12, 2014 | 7,657,781 | 2.6% |
PORTOLA PHARMACEUTICALS INC | February 12, 2014 | 400,000 | 1.0% |
Dicerna Pharmaceuticals Inc | February 10, 2014 | 1,337,000 | 8.0% |
RingCentral Inc | February 07, 2014 | 471,073 | 5.5% |
View Bain Capital Public Equity Management, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2020-11-16 |
13F-HR | 2020-08-14 |
13F-HR | 2020-05-15 |
13F-HR | 2020-02-14 |
13F-HR | 2019-11-14 |
13F-HR | 2019-08-14 |
13F-HR | 2019-05-15 |
13F-HR | 2019-02-14 |
SC 13G/A | 2019-02-14 |
SC 13G/A | 2019-02-14 |
View Bain Capital Public Equity Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.